Abstract:Background: Therapeutic angiogenesis by transplantation of autologous/allogeneic adipose stem cells (ADSCs) is a potential method for the treatment of critical limb ischemia (CLI). However, the therapeutic efficiency is limited by poor viability, adhesion, migration and differentiation after cell transplantation into the target area. Astragaloside IV (AS-IV), one of the main active components of Astragalus, has been widely used in the treatment of ischemic diseases and can promote cell proliferation and angiogenesis. However, there is no report on the effect of AS-IV on ADSCs and its effect on hindlimb ischemia through cell transplantation. Purpose: The purpose of this study was to elucidate that AS-IV pretreatment enhances the therapeutic effect of ADSC on critical limb ischemia, and to characterize the underlying molecular mechanisms. Methods: ADSCs were obtained and pretreated with the different concentration of AS-IV. In vitro, we analyzed the influence of AS-IV on ADSC proliferation, migration, angiogenesis and recruitment of human umbilical vein endothelial cells (HUVECs) and analyzed the relevant molecular mechanism. In vivo, we injected drug-pretreated ADSCs into a Matrigel or hindlimb ischemia model and evaluated the therapeutic effect by the laser Doppler perfusion index, immunofluorescence, and histopathology. Results: In vitro experiments showed that AS-IV improved ADSC migration, angiogenesis and endothelial recruitment. The molecular mechanism may be related to the upregulation of CXC receptor 2 (CXCR2) to promote the phosphorylation of focal adhesion kinase (FAK). In vivo, Matrigel plug assay showed that ADSCs pretreated with AS-IV have stronger angiogenic potential. The laser Doppler perfusion index of the hindlimbs of mice in the ADSC/AS-IV group was significantly higher than the laser Doppler perfusion index of the hindlimbs of mice of the ADSC group and the control group, and the microvessel density was significantly increased. Conclusion: Our results demonstrate that AS-IV pretreatment of ADSC improves their therapeutic efficacy in ameliorating severe limb exclusion symptomology through CXCR2 induced FAK phosphorylation, which will bring new insights into the treatment of severe limb ischemia.

Investigating the Impact of Astragalus Polysaccharide on Angiogenesis in Human Adipose-Derived Stem Cells

Astragaloside Iv Stimulates Angiogenesis And Increases Hypoxia-Inducible Factor-1 Alpha Accumulation Via Phosphatidylinositol 3-Kinase/Akt Pathway

Effects of Astragalus on Number and Activity of Peripheral Endothelial Progenitor Cells

Effects of Astragalus Polysaccharides on Expression of Adiponectin in 3T3-L1 Adipocytes

Effects of Astragalus Polysaccharides on Proliferation and Differentiation of 3T3-L1 Preadipocytes

Astragaloside IV promotes the angiogenic capacity of adipose-derived mesenchymal stem cells in a hindlimb ischemia model by FAK phosphorylation via CXCR2

Astragalus Polysaccharide Improves Insulin Sensitivity Via AMPK Activation in 3T3-L1 Adipocytes

Effects of Astragaloside IV on Pathogenesis of Metabolic Syndrome in Vitro

Effects of Astragalus on Expression of Apelin/APJ in Human Umbilical Vein Endothelial Cells Exposed to High Glucose

Effect of Astragalus Active Ingredients on AdipoR1 and AMPK Mrna Expression in Diabetic Rats

Astragalus polysaccharide improve the proliferation and insulin secretion of mouse pancreatic β cells induced by high glucose and palmitic acid partially through promoting miR-136-5p and miR-149-5p expression

Astragaloside IV Stimulates Angiogenesis and Increases Hypoxia-Inducible Factor-1α Accumulation via Phosphatidylinositol 3-Kinase/Akt Pathway

Astragalus polysaccharide: a review of its immunomodulatory effect

Study of Astragalus Mongholicus Polysaccharides on Endothelial Cells Permeability Induced by HMGB1

Effect of astragalus polysaccharides on peripheral endothelial progenitor cells via PI3K/Akt/eNOS signal pathway in patients with type 2 diabetes

The Effects of Astragalus Polysaccharide on Bone Marrow-Derived Mesenchymal Stem Cell Proliferation and Morphology Induced by A549 Lung Cancer Cells

Astragalus Polysaccharide Regulates Brown Adipogenic Differentiation Through Mir-1258-5p-modulated Cut-Like Homeobox 1 Expression.

GW29-e1665 Effects of Advanced Glycation End Products on Function and Angiogenesis of Adipose Tissue-Derived Stem Cells and Protective Effects of Danhong Injection.

Effects of Astragalus polydsaccharide on proliferation of SPC-A-1

Study on the Effect of Astragalus Polysaccharide on the Proliferation of Human Neuroblastoma SH-SY5Y Cells

Effects of astragalus polysaccharide on cell injury and mitochondrial pathway apoptosis in the hypoxia reoxygenation of myocardial cells